Difference between revisions of "FHIR Adverse Event Resource"
(171 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
[[Category:RCRIM]] | [[Category:RCRIM]] | ||
− | Return to [[ | + | Return to [[http://wiki.hl7.org/index.php?title=Patient_Care_WG | Patient Care] main page |
− | + | Return to [[http://wiki.hl7.org/index.php?title=FHIR_Clinical_Resources_-_PCWG | Patient Care FHIR]] | |
− | ''FHIR Resource Proposal'' | + | ==FHIR Adverse Event== |
+ | |||
+ | FHIR Resource: http://hl7.org/fhir/adverseevent.html (STU 3) | ||
+ | |||
+ | ''Project Number'' '''Project Number 1240''' | ||
+ | |||
+ | ''FHIR Resource Proposal'' [[AdverseEvent_FHIR_Resource_Proposal]] | ||
''Project Name'' '''FHIR Adverse Event Resource''' | ''Project Name'' '''FHIR Adverse Event Resource''' | ||
− | ''Project Sponsor(s)'' [[ | + | ''Project Sponsor(s)'' [[Patient Care WG]] |
+ | ==Description== | ||
− | |||
+ | [http://www.hl7.org/special/Committees/projman/searchableProjectIndex.cfm?action=edit&ProjectNumber=1240 Project Scope Statement - Project 1240] | ||
− | + | '''Thanks to the efforts of Rik Smithies we have a draft build of the FHIR AE resource!!''' | |
+ | http://build.fhir.org/adverseevent.html | ||
==Objectives / Deliverables== | ==Objectives / Deliverables== | ||
− | + | ||
+ | To enhance patient safety, it is noted that many countries have strong needs to exchange product safety information between varieties of stakeholders in the healthcare domain. Currently many regulatory agencies collect safety reports of adverse drug reactions, adverse events, infections, contamination and other incidents from consumers, pharmaceutical companies and healthcare professionals. | ||
+ | |||
+ | The AdverseEvent resource will address the exchange of the following types of information: | ||
+ | |||
+ | 1) Individual Case Safety Report (ICSR): Framework for data exchange and information sharing by providing a common messaging format for transmission of Individual Case Safety Reports (ICSR) for adverse drug reactions (ADR), adverse events (AE), product problems and consumer complaints that may occur upon the administration or use of one or more products or substances. The reports can relate to a specific subject or may be used to relay an issue or finding related to a specific substance, product or device. | ||
+ | |||
+ | 2) (Not in current standard) – Individual Occurrence Report (IOR): The identification and characterization of exceptional events related to patient care, patient safety, protocol implementation, and service delivery. Examples might be falling out of bed, slipping on a wet floor, inappropriate use of restraints. | ||
==Meeting Details== | ==Meeting Details== | ||
− | + | The FHIR Adverse Event resource is discussed during the weekly Patient Care FHIR calls held on Thursdays at 5 PM ET. | |
+ | |||
+ | Agendas: http://wiki.hl7.org/index.php?title=PCWG_FHIR_Conference_Calls_and_Meeting_Minutes | ||
+ | |||
+ | AUDIO - HL7 Teleconference Line: | ||
− | |||
Phone Number: +1 770-657-9270 | Phone Number: +1 770-657-9270 | ||
− | |||
− | + | Participant Passcode: 943377 | |
+ | |||
+ | WEBEX - https://cernermeeting.webex.com/join/michelle.m.miller | 596 965 698 | ||
+ | |||
+ | ==Meeting Agendas / Minutes / Presentations / Publications== | ||
+ | |||
+ | Links are to files. Download, or open in a new Tab or Window. | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2017-06-16.pdf | Call 22 > FHIR AdverseEvent Resource Conf Call on 2017-06-16: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2017-06-02.pdf | Call 21 > FHIR AdverseEvent Resource Conf Call on 2017-06-02: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:Changes_to_Adverse_Event_Resource_2017_04_04.pdf | List of Changes to AdverseEvent Resource 2017-04-04]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2017-04-07.pdf | Call 20 > FHIR AdverseEvent Resource Conf Call on 2017-04-07: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2017-03-24.pdf | Call 19 > FHIR AdverseEvent Resource Conf Call on 2017-03-24: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2017-03-10.pdf | Call 18 > FHIR AdverseEvent Resource Conf Call on 2017-03-10: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2017-2-24.docx | Call 17 > FHIR AdverseEvent Resource Conf Call on 2017-2-24: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2017-2-10.docx | Call 16 > FHIR AdverseEvent Resource Conf Call on 2017-2-10: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2017_1_6.docx | Call 15 > FHIR AdverseEvent Resource Conf Call on 2016-1-06: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_12_09.docx | Call 14 > FHIR AdverseEvent Resource Conf Call on 2016-12-09: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_11_18.docx | Call 13 > FHIR AdverseEvent Resource Conf Call on 2016-11-18: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_10_28.docx | Call 12 > FHIR AdverseEvent Resource Conf Call on 2016-10-28: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_10_21.docx | Call 11 > FHIR AdverseEvent Resource Conf Call on 2016-10-21: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_10_14.pdf | Call 10 > FHIR AdverseEvent Resource Conf Call on 2016-10-14: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_09_02.docx | Call 9 > FHIR AdverseEvent Resource Conf Call on 2016-9-02: Agenda and Minutes]] | ||
+ | *See BRIDG Presentation below | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_08_12.pdf | Call 8 > FHIR AdverseEvent Resource Conf Call on 2016-08-12: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_07_01.pdf | Call 7 > FHIR AdverseEvent Resource Conf Call on 2016-07-01: Agenda and Minutes - includes links to data sources]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_06_24.pdf | Call 6 > FHIR AdverseEvent Resource Conf Call on 2016-06-24: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_06_17.pdf | Call 5 > FHIR AdverseEvent Resource Conf Call on 2016-06-17: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_06_10.pdf | Call 4 > FHIR AdverseEvent Resource Conf Call on 2016-06-10: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_06_03.pdf | Call 3 > FHIR AdverseEvent Resource Conf Call on 2016-06-03: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_05-27.pdf | Call 2 > FHIR AdverseEvent Resource Conf Call on 2016-05-27: Agenda and Minutes]] | ||
+ | |||
+ | [[Media:FHIR_AdverseEvent_Resource_Agenda_and_Minutes_2016_05_20.pdf | Call 1 > FHIR AdverseEvent Resource Conf Call on 2016-05-20: Agenda and Minutes]] | ||
+ | '''PRESENTATIONS''' | ||
− | + | [[Media:Presentation_BRIDG_Adverse_Event_Sub-domain_Summary_2016_09-02.pptx | Call 9 > Presentation, BRIDG Adverse Event Sub-domain Summary, Edward Helton, Smita Hastak, Wendy Ver Hoef, Julie Evans, 2016-09-02]] | |
− | + | [[Media:Presentation_PoojaBabbrah_BiosimilarResearch_PointofCarePartners_2016_08-12.pdf | Call 8 > Presentation, Biosimilar Research, Pooja Babbrah, Senior Consultant, Point of Care Partners, 2016-08-12]] | |
− | + | [[Media:Presentation_DrMitraRocca_FDA_AdverseEventReporting_2016_06-24.pdf| Call 6 > Presentation, FDA Adverse Event Reporting, Dr. Mitra Rocca, 2016-06-24]] | |
− | + | '''PUBLICATIONS''' | |
+ | Publication by Stella Stergiopoulos et al. from Tufts, "A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals" http://link.springer.com/article/10.1007/s40264-016-0455-4 | ||
+ | ==Project Requirements and Use Cases== | ||
− | + | [[Media:Standards_Comparison_of_Data_Elements_2016_10_14.xlsx| FHIR AdverseEvent Resource Data Elements Draft as of 2016-10-14]] | |
+ | [[Media:Adverse_Event_and_Patient_Safety_Use_Cases_for_HL7_FHIR_Adverse_Event_Resource_V2.docx| FHIR AdverseEvent Resource Draft Use Cases V2 2016-10-28]] | ||
+ | [[Media:Adverse_Event_and_Patient_Safety_Use_Cases_for_HL7_FHIR_Adverse_Event_Resource_V3.docx| '''FHIR AdverseEvent Resource Draft Use Cases V2 2016-11-17''']] | ||
==Project References== | ==Project References== | ||
+ | |||
+ | '''FHIR Event Resource Pattern''' | ||
+ | |||
+ | Guidance on standard syntax issued by the FHIR team for any Resource that details event information. | ||
+ | |||
+ | [[Media:FHIR_Event_Resource_Pattern.pdf | FHIR_Event_Resource_Pattern.pdf, July 5, 2016]] | ||
+ | |||
+ | |||
+ | '''Based on TANSI/HL7 V3 ICSRP1, R2-2012''' | ||
+ | |||
+ | '''HL7 Version 3 Standard: Pharmacovigilance - Individual Case Safety Report''' | ||
+ | |||
+ | |||
+ | ICSR Part 1: The Framework for Adverse Event Reporting, R2 | ||
+ | |||
+ | http://www.hl7.org/implement/standards/product_brief.cfm?product_id=266 | ||
+ | |||
+ | |||
+ | ICSR Part 2: Human Pharmaceutical Reporting Requirements for ICSR, R2 | ||
+ | |||
+ | http://www.hl7.org/implement/standards/product_brief.cfm?product_id=267 (medicinals only) | ||
+ | |||
+ | |||
+ | AHRQ Patient Safety Common Format Guidelines | ||
+ | |||
+ | https://www.psoppc.org/psoppc_web/publicpages/supportingDocsV1.2 | ||
+ | |||
+ | |||
+ | FHIR W5 Guidelines: | ||
+ | http://hl7-fhir.github.io/w5.html |
Latest revision as of 19:36, 3 August 2017
Return to [| Patient Care main page
Return to [| Patient Care FHIR]
Contents
FHIR Adverse Event
FHIR Resource: http://hl7.org/fhir/adverseevent.html (STU 3)
Project Number Project Number 1240
FHIR Resource Proposal AdverseEvent_FHIR_Resource_Proposal
Project Name FHIR Adverse Event Resource
Project Sponsor(s) Patient Care WG
Description
Project Scope Statement - Project 1240
Thanks to the efforts of Rik Smithies we have a draft build of the FHIR AE resource!!
http://build.fhir.org/adverseevent.html
Objectives / Deliverables
To enhance patient safety, it is noted that many countries have strong needs to exchange product safety information between varieties of stakeholders in the healthcare domain. Currently many regulatory agencies collect safety reports of adverse drug reactions, adverse events, infections, contamination and other incidents from consumers, pharmaceutical companies and healthcare professionals.
The AdverseEvent resource will address the exchange of the following types of information:
1) Individual Case Safety Report (ICSR): Framework for data exchange and information sharing by providing a common messaging format for transmission of Individual Case Safety Reports (ICSR) for adverse drug reactions (ADR), adverse events (AE), product problems and consumer complaints that may occur upon the administration or use of one or more products or substances. The reports can relate to a specific subject or may be used to relay an issue or finding related to a specific substance, product or device.
2) (Not in current standard) – Individual Occurrence Report (IOR): The identification and characterization of exceptional events related to patient care, patient safety, protocol implementation, and service delivery. Examples might be falling out of bed, slipping on a wet floor, inappropriate use of restraints.
Meeting Details
The FHIR Adverse Event resource is discussed during the weekly Patient Care FHIR calls held on Thursdays at 5 PM ET.
Agendas: http://wiki.hl7.org/index.php?title=PCWG_FHIR_Conference_Calls_and_Meeting_Minutes
AUDIO - HL7 Teleconference Line:
Phone Number: +1 770-657-9270
Participant Passcode: 943377
WEBEX - https://cernermeeting.webex.com/join/michelle.m.miller | 596 965 698
Meeting Agendas / Minutes / Presentations / Publications
Links are to files. Download, or open in a new Tab or Window.
Call 22 > FHIR AdverseEvent Resource Conf Call on 2017-06-16: Agenda and Minutes
Call 21 > FHIR AdverseEvent Resource Conf Call on 2017-06-02: Agenda and Minutes
List of Changes to AdverseEvent Resource 2017-04-04
Call 20 > FHIR AdverseEvent Resource Conf Call on 2017-04-07: Agenda and Minutes
Call 19 > FHIR AdverseEvent Resource Conf Call on 2017-03-24: Agenda and Minutes
Call 18 > FHIR AdverseEvent Resource Conf Call on 2017-03-10: Agenda and Minutes
Call 17 > FHIR AdverseEvent Resource Conf Call on 2017-2-24: Agenda and Minutes
Call 16 > FHIR AdverseEvent Resource Conf Call on 2017-2-10: Agenda and Minutes
Call 15 > FHIR AdverseEvent Resource Conf Call on 2016-1-06: Agenda and Minutes
Call 14 > FHIR AdverseEvent Resource Conf Call on 2016-12-09: Agenda and Minutes
Call 13 > FHIR AdverseEvent Resource Conf Call on 2016-11-18: Agenda and Minutes
Call 12 > FHIR AdverseEvent Resource Conf Call on 2016-10-28: Agenda and Minutes
Call 11 > FHIR AdverseEvent Resource Conf Call on 2016-10-21: Agenda and Minutes
Call 10 > FHIR AdverseEvent Resource Conf Call on 2016-10-14: Agenda and Minutes
Call 9 > FHIR AdverseEvent Resource Conf Call on 2016-9-02: Agenda and Minutes
- See BRIDG Presentation below
Call 8 > FHIR AdverseEvent Resource Conf Call on 2016-08-12: Agenda and Minutes
Call 6 > FHIR AdverseEvent Resource Conf Call on 2016-06-24: Agenda and Minutes
Call 5 > FHIR AdverseEvent Resource Conf Call on 2016-06-17: Agenda and Minutes
Call 4 > FHIR AdverseEvent Resource Conf Call on 2016-06-10: Agenda and Minutes
Call 3 > FHIR AdverseEvent Resource Conf Call on 2016-06-03: Agenda and Minutes
Call 2 > FHIR AdverseEvent Resource Conf Call on 2016-05-27: Agenda and Minutes
Call 1 > FHIR AdverseEvent Resource Conf Call on 2016-05-20: Agenda and Minutes
PRESENTATIONS
Call 6 > Presentation, FDA Adverse Event Reporting, Dr. Mitra Rocca, 2016-06-24
PUBLICATIONS
Publication by Stella Stergiopoulos et al. from Tufts, "A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals" http://link.springer.com/article/10.1007/s40264-016-0455-4
Project Requirements and Use Cases
FHIR AdverseEvent Resource Data Elements Draft as of 2016-10-14
FHIR AdverseEvent Resource Draft Use Cases V2 2016-10-28
FHIR AdverseEvent Resource Draft Use Cases V2 2016-11-17
Project References
FHIR Event Resource Pattern
Guidance on standard syntax issued by the FHIR team for any Resource that details event information.
FHIR_Event_Resource_Pattern.pdf, July 5, 2016
Based on TANSI/HL7 V3 ICSRP1, R2-2012
HL7 Version 3 Standard: Pharmacovigilance - Individual Case Safety Report
ICSR Part 1: The Framework for Adverse Event Reporting, R2
http://www.hl7.org/implement/standards/product_brief.cfm?product_id=266
ICSR Part 2: Human Pharmaceutical Reporting Requirements for ICSR, R2
http://www.hl7.org/implement/standards/product_brief.cfm?product_id=267 (medicinals only)
AHRQ Patient Safety Common Format Guidelines
https://www.psoppc.org/psoppc_web/publicpages/supportingDocsV1.2
FHIR W5 Guidelines:
http://hl7-fhir.github.io/w5.html